LinkOPH

Patients’ expectations have changed over the past several years with regard to what types of servic…

Read more →

.text img {margin-top: 0 !important;}

img src=”http://eyetubeod.co…

Read more →

Meibomian gland dysfunction (MGD) is characterized by abnormal composition and/or abnormal secretion…

Read more →

Shire Releases Positive OPUS-3 Phase 3 Trial Results for Lifitegrast; Remains on Track for 2016 Launch
Shire announced topline results from OPUS-3, a phase 3 efficacy and safety study of the company’s le…

Read more →

img src=”http://eyetubeod.com/images/articles/2015-10/kading_david2014_bw.pn…

Read more →